Tarsus Pharmaceuticals (TARS) Change in Acquisitions & Divestments (2022 - 2026)

Tarsus Pharmaceuticals' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $74.1 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 18.82% year-over-year to $74.1 million; the TTM figure through Mar 2026 stood at $344.6 million (up 113.11% YoY), while the FY2025 annual figure was $361.8 million, up 395.62% from the prior year.
• Change in Acquisitions & Divestments was $74.1 million for Q1 2026 at Tarsus Pharmaceuticals, down from $92.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $99.5 million in Q3 2025 to a low of $2.5 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $49.2 million across 5 years, with a median of $46.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments tumbled 93.8% in 2024, then soared 3548.72% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $5.3 million in 2022, then soared by 235.84% to $17.8 million in 2023, then surged by 98.68% to $35.5 million in 2024, then surged by 159.64% to $92.1 million in 2025, then dropped by 19.58% to $74.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $74.1 million (Q1 2026), $92.1 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.